Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness

被引：2

作者：

Ariane, Molka ^{[1
]}

Bouaziz, Jean-David ^{[1
,2
]}

de Masson, Adele ^{[1
,2
]}

Jachiet, Marie ^{[1
,2
]}

Bagot, Martine ^{[1
,2
]}

Lepelletier, Clemence ^{[1
,2
]}

机构：

[1] Hop St Louis, AP HP, Dept Dermatol, Paris, France

[2] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France

来源：

DERMATOLOGIC THERAPY | 2019年 / 32卷 / 01期

关键词：

etanercept; postoperative pyoderma gangrenosum; serum sickness;

D O I：

10.1111/dth.12774

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Non-peristomal postoperative pyoderma gangrenosum (PPG) is a rare subtype of pyoderma gangrenosum that occurs in the early postoperative period at surgical incisions, most commonly after breast surgery. Early diagnosis and treatment is essential to prevent severe scaring. TNF-alpha inhibitor infliximab was reported to be efficient in treatment of PPG refractory to systemic corticosteroids. However infliximab can be not well tolerated. We report the first case of etanercept efficacy in post-plastic breast surgery pyoderma gangrenosum after infliximab serum sickness.

引用

页数：2

共 6 条

[1] Etiology and Management of Pyoderma Gangrenosum A Comprehensive Review [J].